Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Since the 1950s, researchers have been trying to mimic the abilities of red blood cells. These flexible discs carry oxygen throughout the body, squeezing through the smallest capillaries to do so. But the physical characteristics of red blood cells, including their doubly concave shape, have made them difficult to copy with precision.

In research published Monday in the Proceedings of the National Academy of Sciences, a group specializing in drug delivery has found a way to create biodegradable, biocompatible particles with the size, shape, and flexibility of red blood cells. The group believes these artificial cells might be particularly effective not just for carrying oxygen but also as therapeutic and imaging agents.

“People have made over a thousand different polymers of different sizes for drug delivery. But if you look at them all together, they represent the synthetic world; the particles are nice and spherical,” says Samir Mitragotri, a chemical engineer at the University of California at Santa Barbara, who led the new work. “If you look at the biological world, nature uses all kinds of particles for delivering its own goods. Bacteria, cells, viruses are all designed to perform very specific delivery functions.”

To create the synthetic cells, Mitragotri, along with researchers at the University of Michigan, start with spherical particles made of a common polymer called poly(lactic-co-glycolic acid (PLGA), a compound known for its biocompatible and biodegradable properties. They expose the spheres to rubbing alcohol, which causes them to deflate and collapse into the dimpled shape of a red blood cell. The hard PLGA particle acts as a mold, around which the researchers can deposit layer after layer of proteins. They crosslink the proteins to get them to hold to the PLGA, then dissolve the rigid inner structure. The result is a soft, flexible protein shell the size and shape of a red blood cell. The researchers can also vary the protein coatings depending, for example adding hemoglobin, which could carry oxygen.

So far, Mitragotri has shown that the particles are flexible enough to compress and flow through capillary-sized tubes, and can be infused with drugs at just about every stage of the process. His group has also encapsulated iron-oxide nanoparticles in the synthetic cells, creating a potential contrast agent for MRIs. “One can imagine putting these particles into the blood and using them to visualize blood flow,” Mitragotri says.

“Overall, I’ve never seen anything like it. Both the concept and the fabrication methods they developed are very interesting,” says Ali Khademhosseini, a biomedical engineer at the Harvard-MIT Division of Health Sciences and Technology. “There’s an increasing appreciation about how the shape of particles is important for a variety of different things, like the hydrodynamics of particles inside fluid, or how different biological entities interact with them.”

0 comments about this story. Start the discussion »

Credit: Nishit Doshi

Tagged: Biomedicine, imaging, blood, drug delivery, biology, microbiology

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me